Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Figure 3

Forest plots of sensitivity (a), specificity (b), and area under the curve (c) of circulating miRNAs for diagnosing nonalcoholic fatty liver disease among 17 studies. Forest plots of sensitivity (d), specificity (e), and area under the curve (f) of microRNA-122 for diagnosing nonalcoholic fatty liver disease among four studies.

(a)

(b)

(c)

(d)

(e)

(f)